[go: up one dir, main page]

DE2534963A1 - Piperazino-pyrimidine und diese verbindungen enthaltende arzneimittel - Google Patents

Piperazino-pyrimidine und diese verbindungen enthaltende arzneimittel

Info

Publication number
DE2534963A1
DE2534963A1 DE19752534963 DE2534963A DE2534963A1 DE 2534963 A1 DE2534963 A1 DE 2534963A1 DE 19752534963 DE19752534963 DE 19752534963 DE 2534963 A DE2534963 A DE 2534963A DE 2534963 A1 DE2534963 A1 DE 2534963A1
Authority
DE
Germany
Prior art keywords
group
compounds
carbon atoms
piperazino
product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19752534963
Other languages
German (de)
English (en)
Inventor
Gerard Loiseau
Georges Mattioda
Rene Dr Millischer
Pierre Obellianne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ugine Kuhlmann SA
Original Assignee
Ugine Kuhlmann SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ugine Kuhlmann SA filed Critical Ugine Kuhlmann SA
Publication of DE2534963A1 publication Critical patent/DE2534963A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE19752534963 1974-08-09 1975-08-05 Piperazino-pyrimidine und diese verbindungen enthaltende arzneimittel Withdrawn DE2534963A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7427671A FR2281117A2 (fr) 1974-08-09 1974-08-09 Nouvelles piperazino-pyrimidines utilisables comme medicaments

Publications (1)

Publication Number Publication Date
DE2534963A1 true DE2534963A1 (de) 1976-02-19

Family

ID=9142279

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19752534963 Withdrawn DE2534963A1 (de) 1974-08-09 1975-08-05 Piperazino-pyrimidine und diese verbindungen enthaltende arzneimittel

Country Status (13)

Country Link
JP (2) JPS51125089A (no)
AR (1) AR205579A1 (no)
BE (1) BE832277R (no)
CA (1) CA1036598A (no)
CH (1) CH609692A5 (no)
DE (1) DE2534963A1 (no)
ES (1) ES440153A2 (no)
FR (1) FR2281117A2 (no)
GB (1) GB1512101A (no)
LU (1) LU73175A1 (no)
NL (1) NL7509184A (no)
NO (1) NO752586L (no)
ZA (1) ZA755118B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2417507A2 (fr) * 1977-07-28 1979-09-14 Ugine Kuhlmann Diamino-2,4 (ou -4,6) methylthio-5 pyrimidines herbicides
FR2503162A1 (fr) * 1981-04-07 1982-10-08 Pharmindustrie Nouveaux derives de piperazino-2 pyrimidine, procedes pour leur preparation et leur utilisation comme medicaments ou comme intermediaires pour la fabrication de medicaments
JPS5973573A (ja) * 1982-09-09 1984-04-25 ワ−ナ−−ランバ−ト・コンパニ− ジアミノピリミジン化合物
US6825198B2 (en) 2001-06-21 2004-11-30 Pfizer Inc 5-HT receptor ligands and uses thereof
MXPA06000051A (es) 2003-07-02 2006-03-21 Vertex Pharma Pirimidinas utiles como moduladores de canales ionicos dependientes de voltaje.
JP5388574B2 (ja) 2005-05-31 2014-01-15 バーテックス ファーマシューティカルズ インコーポレイテッド イオンチャネルのモジュレーターとして有用なヘテロ環式類

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2307536A1 (de) * 1972-03-01 1973-09-13 Ugine Kuhlmann Neue pyrimidinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2119234A5 (en) * 1970-12-24 1972-08-04 Ugine Kuhlmann 5-alkylthio amino halopyrimidines - fungicides herbicides insecticides and bactericides

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2307536A1 (de) * 1972-03-01 1973-09-13 Ugine Kuhlmann Neue pyrimidinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
JPS58150571A (ja) 1983-09-07
JPS51125089A (en) 1976-11-01
ES440153A2 (es) 1977-07-01
LU73175A1 (no) 1976-03-02
ZA755118B (en) 1976-07-28
GB1512101A (en) 1978-05-24
BE832277R (fr) 1976-02-09
AR205579A1 (es) 1976-05-14
FR2281117A2 (fr) 1976-03-05
NL7509184A (nl) 1976-02-11
JPS5946943B2 (ja) 1984-11-15
NO752586L (no) 1976-02-10
FR2281117B2 (no) 1978-07-28
CH609692A5 (en) 1979-03-15
CA1036598A (fr) 1978-08-15

Similar Documents

Publication Publication Date Title
DE928345C (de) Verfahren zur Herstellung von 10-(3'-Pyrrolidino-propyl)-phenthiazin und seinen Salzen bzw. seinen quaternaeren Ammoniumverbindungen
DE2555590A1 (de) 1-substituierte-4-benzylidenpiperidine und verfahren zu ihrer herstellung
DE2800954A1 (de) Derivate des meta-trifluoromethylphenylpiperazins und deren verwendung als arzneimittel
DE2167193C2 (de) 4-(4-Hydroxypiperidino)-N,N,3-trimethyl-2,2-diphenylbutyramide und Verfahren zu ihrer Herstellung
DE2534963A1 (de) Piperazino-pyrimidine und diese verbindungen enthaltende arzneimittel
DE69230498T2 (de) 2-Pyrazinylethylamin-Derivate und ihre Verwendung als Arzneimittel.
DE2307536C3 (de) 2-Methylamino-4-(4-methylpiperazino)-5-methylthio-6-chlorpyrünidin, Verfahren zu dessen Herstellung und dieses enthaltende Arzneimittel
DE3112984A1 (de) 2-(3-(4-(3-chlor-4-fluorphenyl)-1-piperazinyl) propyl)-1,2,4-triazolo(4,3-a)pyridin-3(2h)-on dessen pharmazeutische anwendung und herstellung
DE2847624A1 (de) Arylaether von n-alkyl-piperidinen und deren saeureadditionssalze, verfahren zu ihrer herstellung und ihre verwendung
DE3028064C2 (no)
DE2513136B2 (de) N-(I -Benzylpiperid-4-yl)-benzamide, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate
WO1982002891A1 (en) Amino-2,1,3-benzothiadiazol and benzoxadiazol derivatives,preparation thereof and drugs containing them
DE1518311B1 (de) N-(2-Diaethylaminoaethyl)-2-methoxy-3,4- bzw. 4,5-methylendioxybenzamid und deren pharmakologisch nicht giftige Saeureadditionssalze
DE1568734C3 (de) N-Dialkyl-aminoalkyl-S-diphenylsulfoximine und ihre Salze sowie Verfahren zu ihrer Herstellung
DE2366224C2 (de) 1- [3-(l-Äthinyl)- cyclohexyloxy-2-hydroxy] -propyl-4-phenylpiperazin-derivate, deren Salze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE1695785B2 (de) 2-aminomethyl-benzofurane, verfahren zu deren herstellung sowie diese verbindungen enthaltende praeparate
DE1545774C3 (de) 3-Äthyl-4,5,6,7-tetrahydro-2methyl-5-morpholinomethyl-4-oxoindol, Verfahren zu seiner Herstellung und pharmazeutische Zusammensetzungen
DE1695765B2 (de) In 1-stellung n-heterocyclisch substituierte derivate des propan-2,3diols
DE2836061A1 (de) 1-substituierte-3-pyrrolidinylaminocarbonyl(-und -thiocarbonyl-)oxanilinsaeure, -ester und metallsalze davon, verfahren zu ihrer herstellung und verwendung als arzneimittel.
DE2337414C3 (de) 1 (m-Chlorphenyl)-3- [2-(33-dimethylazetidin-1 -yl)ethyl] -2-imidazolidinon und dessen pharmazeutisch akzeptablen Salze sowie Verfahren zu deren Herstellung
AT336568B (de) Verfahren zur herstellung von neuen n'-(aminoacylaminophenyl)-acetamidinen
DE1518311C (de) N (2 Diathylaminoathyl) 2 methoxy 3,4 bzw 4,5 methylendioxybenzamid und deren pharmakologisch nicht giftige Saureadditions salze
AT275522B (de) Verfahren zur Herstellung von neuen subtituierten Alkylenpiperidinen und von deren pharmazeutisch verwendbaren Salzen
DE1111209B (de) Verfahren zur Herstellung eines neuen Phenylalkylolamins mit hustenreizstillenden Eigenschaften
DE1802631A1 (de) Neue chemotherapeutisch wirksame tricyclische Aminoketone und Verfahren zu deren Herstellung

Legal Events

Date Code Title Description
OGA New person/name/address of the applicant
8110 Request for examination paragraph 44
8162 Independent application
8128 New person/name/address of the agent

Representative=s name: SCHWABE, H., DIPL.-ING. SANDMAIR, K., DIPL.-CHEM.

8125 Change of the main classification

Ipc: C07D239/48

8136 Disposal/non-payment of the fee for publication/grant